Abstract Oral Presentation

Moderator(s)

• 

  Jad Sfeir, MD, MS, FACP

  Assistant Professor of Medicine
  Mayo Clinic
  Rochester, Minnesota, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentations:

• 11:15 AM – 11:30 AM

  A Novel Anti-FcRn Antibody Markedly Decreases the Pathogenic Stimulatory TSH Receptor Antibodies in Thyroid Eye Disease
  

  Submitter: George J. Kahaly, MD, PhD – Johannes Gutenberg University Medical Center

  Submitter: Jonathan Janes
• 11:30 AM – 11:45 AM

  Crystal Bone: Validation of a Novel AI/ML Algorithm in the Optum Reliant Dataset to Identify Patients at Risk of Osteoporotic Fracture in the Next 2 Years
  

  Submitter: Cynthia Deignan, PhD – Amgen Inc.
• 11:45 AM – 12:00 PM

  Once Daily, Oral Nonpeptide Somatostatin Receptor Type 2 (SST2) Specific Agonist Paltusotine is Associated with Long-Term Toleration and Efficacy in Patients with Acromegaly Enrolled in ACROBAT Advance, a Phase 2 Open Label Extension Study
  

  Submitter: Alessandra Casagrande